ACLARUBICIN vs ADAGRASIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ACLARUBICIN vs ADAGRASIB: Safety Overview
| Metric | ACLARUBICIN | ADAGRASIB |
|---|---|---|
| Total FAERS Reports | 314 | 899 |
| Deaths Reported | 60 | 315 |
| Death Rate | 19.1% | 35.0% |
| Hospitalizations | 73 | 350 |
| Average Patient Age | 51.1 yrs | 68.3 yrs |
| % Female Patients | 47.2% | 56.4% |
| FDA Approval Date | N/A | Dec 12, 2022 |
| Manufacturer | N/A | Mirati Therapeutics, Inc |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |